about
Identification of the emerging pathogen Vibrio vulnificus biotype 3 by commercially available phenotypic methods.Usefulness of blood cultures in the management of febrile patients in long-term care facilities.Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.Distribution and characteristics of Escherichia coli clonal group A.Who are you--Staphylococcus saprophyticus?Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists.Measurement of betamethasone concentration in maternal serum treated for fetal lung maturity; Is it feasible?Etiology of community-acquired pneumonia in hospitalized patients in northern Israel.Adult calcific aortic stenosis and Chlamydia pneumoniae: the role of Chlamydia infection in valvular calcification.Seasonal Influenza Vaccination Effectiveness and Compliance among Hospital Health Care Workers.Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study.Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics.Acute otitis media in infants less than three months of age: clinical presentation, etiology and concomitant diseases.Early onset of neonatal Streptococcus pneumoniae bacteremia and septic arthritis.Clinical predictors of streptococcal pharyngitis in adults.[Salmonella virchow sacroiliitis and bacteremia in a child]Campylobacter bacteremia and pneumonia in two splenectomized patients.Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.Chloramphenicol use and susceptibility patterns in Israel: a national survey.Is chloramphenicol making a comeback?Antimicrobial susceptibility of community-acquired uropathogens in northern Israel.Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli.Procalcitonin as a marker of acute pyelonephritis in infants and children.Improved antimicrobial susceptibility of community-acquired uropathogens in northern Israel (1995-1999-2002).Bacteriological aspects of Darier's disease.Long-term follow-up of women hospitalized for acute pyelonephritis.Seasonal variation in Escherichia coli bloodstream infections in northern Israel.Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.Age-related seroprevalence of Cryptosporidium in northern Israel.Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.Adherence to guidelines on empiric use of antibiotics in the emergency room.Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases.Intraoperative Parathyroid Aspiration and Parathyroid Hormone Assay During Parathyroidectomy for Primary Hyperparathyroidism.Streptococcal necrotizing fasciitis with toxic shock syndrome following cervical adenitis.Extended-spectrum beta-lactamases: the end of cephalosporins?Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.Detection of Ureaplasma Species by a Semi-Quantitative PCR Test in Urine Samples: Can It Predict Clinical Significance?
P50
Q30958730-29BC1063-E7C3-47D4-AA03-F45F84B33D36Q33369446-50846E8D-F03F-4C4C-89AF-6CC280A7F600Q33555328-EC7AE496-1C41-4DE6-8503-2B1D6DE33E23Q35804306-E2DFB01D-3E67-4D47-9705-56D3D205EEF7Q36056890-A5996D97-B02F-4730-9877-EE20864FEB7CQ36068224-07D308E2-3E3D-4AFF-A80B-FC1F2DB301C9Q36565762-047DB188-DC22-4870-B056-5FB5512E1AEDQ37851337-9F7F9729-B86D-4C44-96A7-C38975C035BEQ37861716-95E662A3-8D5D-4D36-87AD-870F0B3D2989Q39931408-54582EA1-8F6B-44D9-A302-F4F612B79916Q40314268-31FB0C9C-2D08-40B8-B7B9-D419A9B959B0Q40431354-7EA8AE4F-B5B0-45BA-B030-40C8FB7F3BADQ40499033-928F2631-E290-4041-AD46-CC96EBC90105Q40530101-8A60F35F-6A33-430D-A96B-CFA8798629F3Q40555547-C79B0C8E-5E34-4CEC-9301-9D67058F654FQ40575190-7BFA3390-BADE-4367-8033-E3B5F2F9C344Q40633089-0542BB11-DF37-4C44-8F44-98C023033BC8Q40968807-62095D5E-79FF-4FB7-A399-9D28FAF96DCDQ41297452-E48CEBD4-F523-4E28-AD4B-F0C47F04A1A7Q42867618-30590B85-0F6A-486D-836A-A505D57477DEQ43715696-BDFC8578-0FAD-4A81-94C2-1C23D05EEA2CQ43968132-0E998DD7-CDF8-4ABC-82C6-AFB53C0FDC4AQ44055753-C544C8B2-5428-442D-9E2A-068B95D4BEB1Q44105524-E11B6418-9FAC-43A7-B682-8737A7A1517FQ44202949-EC00832A-A100-4494-9E67-3CF2CDD43D15Q44605669-B71534B6-DCBF-456B-A4AE-4AEDAE9AD1AAQ44609222-2119F372-78DE-42E7-9D22-F7C06CA8D06AQ44835361-5348F94C-0CA3-4D12-9F6B-E90DE56F1A05Q44878759-C81F0EA8-0427-406B-84DE-F1A359284719Q45112520-9E6B8FFB-010F-4E55-B53E-C6B2590B8F09Q45392358-9ACC6A91-E4C4-4146-8BF8-E2CDBFD78238Q46572506-3156992D-7F05-46AD-937A-710BB9975A0FQ46809473-6F01592F-C1B9-4462-ABAD-29F502D50275Q46846730-ABAC3E94-4E65-4B23-8531-DCEA9DBB8018Q46896446-F30E849C-5C3B-4898-AD8B-AC0EDACE8B0CQ49859045-8169DF62-2B11-4871-872E-D2427348749CQ53615169-DCE27239-9E9B-4606-BF35-D5B03D282296Q53856377-722D8905-28A2-4DA1-9809-09614D414E96Q53974291-F6CB0F77-3134-478A-9DAD-42DB629D0934Q54235407-B99E81F7-D518-48C0-A331-0A5B89F54B1E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
R Colodner
@ast
R Colodner
@en
R Colodner
@es
R Colodner
@nl
type
label
R Colodner
@ast
R Colodner
@en
R Colodner
@es
R Colodner
@nl
prefLabel
R Colodner
@ast
R Colodner
@en
R Colodner
@es
R Colodner
@nl
P106
P31
P496
0000-0001-9752-1053